Stevanato Group S.p.A. reported €1.19B of revenue over the trailing twelve months, +41% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: €1.19B (to FY2025). Net Income: €140M, trailing twelve months to FY2025. Free Cash Flow: €22M, trailing twelve months to FY2025. Op Margin: 17%, trailing twelve months to FY2025.

STVNStevanato Group S.p.A.

HealthcareUSD

$22.42

$13.3852 weeks$27.51

STVN as reported

Stevanato Group S.p.A. reported €1.19B of revenue over the trailing twelve months, +41% on the year before. 10 reported series are charted on this page, each one as filed.

€1.19B

Revenue, trailing twelve months · to FY2025 · +41% against the twelve months before

Net Income: €140M
Net Income · +4.1% year on year · trailing twelve months to FY2025
Free Cash Flow: €22M
Free Cash Flow · −13% year on year · trailing twelve months to FY2025
Op Margin: 17%
Op Margin · trailing twelve months to FY2025

Every series Ryufin has for STVN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	€1.19B	+41%	FY2025
Net Income	€140M	+4.1%	FY2025
EPS	€0.51	−3.8%	FY2025
Gross Margin	29%	n/a	FY2025
Op Margin	17%	n/a	FY2025
Net Margin	12%	n/a	FY2025
ROE	9.4%	n/a	FY2025
ROA	5.5%	n/a	FY2025
ROIC	8.7%	n/a	FY2025
Free Cash Flow	€22M	−13%	FY2025